comprehensive -WSS

comprehensive

author：leisure time 2025-08-25 07:30:05 - browse：62

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Empower primary care with adequate payments and technology

knowledge

WSS

BIO to announce reorganization, senior leaders expected to depart

Medicare drug price negotiation hearing pits pharma v Biden admin

Ancient Greek ideas underpin modern concepts of pregnancy

Novel spinal cord stimulator treats paralysis without surgery

IVF doctors demand details after CooperSurgical lawsuit

State of the Union pitch: Bigger Medicare drug price negotiations

hotspot

comprehensive

leisure time

At least 13 dead in Texas as scorching temps continue

Medicare drug price negotiation hearing pits pharma v Biden admin

Supreme Court strikes down use of affirmative action

PBM executives asked to testify by House panel

State Dept. review finds Biden bears some blame for Afghanistan failures

Lawmakers grill UnitedHealth CEO on Change cyberattack

The high cost of giving birth even with insurance

As health system earnings go up, health insurance stocks go down

How one medical school became remarkably diverse

Primary care doctor shortage won't be solved by free med school tuition

explore

Primary care doctor shortage won't be solved by free med school tuition

HHS's proposed rule does nothing to address the climate crisis

Has Bernie Sanders reached the limit of his pharma bullying effort?

The creative science of coining drug names

The public health thinking behind the CDC’s new Covid guidance

IVF doctors demand details after CooperSurgical lawsuit

leisure time

knowledge

focus

focus